How reliable is NGS in diagnosing AML?
Christopher Gibson, MD, of Dana-Farber Cancer Institute, Boston, MA, discusses the reliability of next-generation sequencing (NGS) at the 2018 Society of Hematologic Oncology (SOHO) Annual Meeting, he...
Author: VJHemOnc
Added: 09/19/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts